Targetting special populations for tobacco intervention in managed care
Facilitating smoking cessation in cancer patients
Ellen R Gritz
MD Anderson
Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA;
egritz@mdanderson.org
| The first 150 words of the full text of this article appear below. |
| |
Article |
|---|
Smoking is directly attributable to almost one third of cancer deaths, including causal relationships with cancers of the lung, oral cavity, larynx, and oesophagus, and linkages to cancers of the bladder, pancreas, kidney, stomach, and uterine cervix.1 2 Treating nicotine addiction is an obvious component of any disease management program for cancer patients, but also requires explicit and sensitive tailoring to meet patient needs.
Lung cancer patients who smoke often experience tremendous guilt and
responsibility for their disease, and feel it might be too late for
them. Others, like head and neck cancer patients, may not be aware of
the relation of their smoking to their cancer. By discussing the causal
risk factors related to their disease and how tobacco use jeopardizes
their treatment (for example, impairing wound healing, compromising the
immune system, increasing the risk of developing another cancer, and
reducing their likelihood of survival), many patients can be propelled
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
